The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer
- Type
- Retraction
- Notice date
- 4/26/2017 0:00
- Journal
- OncoTargets and Therapy
- Publisher
- Taylor and Francis - Dove Press
- Notice DOI
- 10.2147/ott.s140498
- Original paper DOI
- 10.2147/ott.s132806
Reasons
- Concerns/Issues about Data
- Concerns/Issues about Results and/or Conclusions
- Unreliable Results and/or Conclusions